---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-061642"
form_type: "8-K"
ticker: "ONCO"
cik: "0001782107"
company_name: "Onconetix, Inc."
filed_at: "2023-08-01T23:59:59+00:00"
generated_at: "2026-06-12T18:43:15.449483+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Blue Water Biotech raises ~$2.7M via warrant exercise inducement; issues new warrants for 4.97M shares

## Summary
- Holder exercises existing warrants for 2,486,214 shares at reduced price of $1.09/share; gross proceeds ~$2.7M.
- Company issues new warrants to purchase up to 4,972,428 shares at $1.09/share, exercisable for 5 years after stockholder approval.
- Proceeds used for working capital and launch activities for commercial portfolio; closing expected August 2, 2023.
- H.C. Wainwright acts as placement agent; receives 7.5% cash fee plus warrants.
- New warrants and shares unregistered; resale registration statement to be filed within 90 days.

## SEC filing metadata
- accession: 0001213900-23-061642
- form_type: 8-K
- ticker: ONCO
- cik: 0001782107
- company_name: Onconetix, Inc.
- filed_at: 2023-08-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1782107/000121390023061642/0001213900-23-061642-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1782107/000121390023061642/ea182607-8k_bluewater.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-061642
- JSON: https://secwatch.observer/filing/0001213900-23-061642.json
- Plain text: https://secwatch.observer/filing/0001213900-23-061642.txt

## Key facts
- Material Agreements
  Onconetix, Inc. entered into Inducement Letter with a certain holder of existing preferred investment options valued at approximately $2,709,973 (effective 2023-07-31).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: a certain holder of existing preferred investment options
  - Value: approximately $2,709,973
  - Effective: 2023-07-31
  source text: On July 31, 2023, Blue Water Biotech, Inc., a Delaware corporation (the “Company”), entered into a common stock preferred investment options exercise inducement offer letter (the “Inducement Letter”) with a certain holder (the “Holder”) of existing preferred investment options (“PIOs”) to purchase shares of the Company’s common stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1782107/000121390023061642/0001213900-23-061642-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.